ACOG
Alpha Cognition Inc.+0.50 (+6.10%) At close · Today 4:00 PM ET
About ACOG
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Moved with Biotech peers: MRNA +13.10% · VCEL +10.67% · PCVX +7.90%
From market data · Not investment advice
Moved with Biotech peers: MRNA +13.10% · VCEL +10.67% · PCVX +7.90%
From market data: the larger companies in its group moved the same way. No report names a cause yet.
Last check 7:30 PM ET
From market data · Not investment adviceSign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about ACOG?
Board · 0 threads
Open board ›No threads yet
Community opinions, not advice. Posts with a target get a receipt. How receipts work ›